If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Block listing Interim Review

31 Mar 2020 07:00

RNS Number : 1186I
Circassia Pharmaceuticals Plc
31 March 2020
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 31st March 2020

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia EMI Share Option Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

700,750

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

700,750

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2007 Unapproved Share Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

203,000

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

203,000

 

 

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2014 Performance Share Plan Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

76,676

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

76,676

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2015 Performance Share Plan Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

280,612

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(4,442)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

276,170

 

 

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2016 Performance Share Plan Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

812,071

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(26,902)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

785,169

 

 

 

Name of contact:

Michael Roller

Telephone number of contact:

01865 405 560

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRWPUCGWUPUGQU

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS